Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases

Transfusion

Volumn 50, Issue 11, 2010, Pages 2318-2327

  Pai, Shun Chung ^a,b,c   Lo, Shyh Chyi ^a,b,c   Lin Tsai, Su Jen ^a,b,c   Chang, Ji Sheng ^a,b,c   Lin, Dong Tsamn ^a,b,c   Lin, Kuo Sin ^a,b,c   Lin, Liang In ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Taiwan Blood Services Foundation   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; EPITOPE; HLA ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOIMMUNIZATION; ANTIBODY SCREENING; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA, APLASTIC; ANTIGENS, HUMAN PLATELET; BLOOD PLATELETS; CROSS REACTIONS; EPITOPE MAPPING; EPITOPES; FEMALE; HEMATOLOGIC DISEASES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PLATELET TRANSFUSION; PROSPECTIVE STUDIES; SOFTWARE;

EID: 78349279139     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02703.x     Document Type: Article

References (18)

1. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R,. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106 -14.
2. Hod E, Schwartz J,. Platelet transfusion refractoriness. Br J Haematol 2008; 142: 348 -60.
3. Duquesnay RJ, Filip DJ, Rodey GE, Aster RH,. Transfusion therapy of refractory thrombcytopenic patients with platelets from donors selectively mismatched for cross-reactive HLA antigens. Transplant Proc 1977; 9: 221 -4.
4. Moroff G, Garratty G, Heal JM, MacPherson BR, Stroncek D, Huang ST, Ho W, Petz LD, Leach MF, Lennon SS, Rowe JM, Saleh MN, Arndt P, Foley K, Masel D, Postoway N,. Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion 1992; 32: 633 -40.
5. Laundy GJ, Bradley BA, Rees BM, Younie M, Hows JM,. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia. Transfusion 2004; 44: 814 -25.
6. Duquesnoy RJ,. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Transfusion 2008; 48: 221 -7.
7. Nambiar A, Duquesnoy RJ, Adams S, Zhao Y, Oblitas J, Leitman S, Stroncek D, Marincola F,. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood 2006; 107: 1680 -7.
8. Brooks EG, MacPherson BR, Fung MK,. Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions. Transfusion 2008; 48: 2159 -66.
9. Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH,. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977; 2: 219 -26.
10. Duquesnoy RJ,. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006; 67: 847 -62.
11. Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, Gornbein JA, Landaw EM, Smith R, Cecka JM,. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 2000; 40: 1446 -56.
12. Zimmermann R, Wittmann G, Zingsem J, Blasczyk R, Weisbach V, Eckstein R,. Antibodies to private and public HLA class I epitopes in platelet recipients. Transfusion 1999; 39: 772 -80.
13. Mueller-Eckhardt G, Hauck M, Kayser W, Mueller-Eckhardt C,. HLA-C antigens on platelets. Tissue Antigens 1980; 16: 91 -4.
14. TRAP. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337: 1861 -9.
15. Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE,. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 2004; 103: 333 -9.
16. Schiffer CA,. Management of patients refractory of platelet transfusion. Leukemia 2001; 15: 683 -5.
17. El-Awar NR, Akaza T, Terasaki PI, Nguyen A,. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007; 84: 532 -40.
18. Rodey GE, editor. HLA beyond tears: introduction to human histocompatibility, 2nd ed. Atlanta (GA): De Novo, Inc.; 2000.